Buy Signal – Woodside Petroleum
The current price retracement in WPL to $31.00 provides a low risk entry point.
WPL is a current holding in the ASX 20 and ASX 50 model portfolios.
The current price retracement in WPL to $31.00 provides a low risk entry point.
WPL is a current holding in the ASX 20 and ASX 50 model portfolios.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
After a year of negotiations and due diligence, the Australian Competition Tribunal (ACT) has approved the $11 billion merger of TABCORP and Tatts Group.
Despite an objection by the ACCC, the ACT granted the merger and will announce the full details of their decision on November 22nd.
Tatts Group shareholders will vote on the merger on November 30th, which is expected to just be a formality.
Both shares have been placed in a trading halt this morning.
After trading as low as $3.90 on August 14th, shares of TAH have been moving steadily higher as the prospects of the merger approval have increased. The synergies of the merger could see TAH shares rally into the $5.60 area.
CBA and SUN have Algo Engine sell signals suggesting both names are currently overbought.
ANZ, NAB & WBC have buy signals. The most recent signal in this group has been yesterday’s buy signal on WBC. Following this the stock has now been added to the model portfolio.
The graph below shows the recent price action for the MVB (Vaneck Vectors Bank ETF).
Our Algo Engine triggered a buy signal in IFL on the 1st Nov and we’ve added this to our model portfolio with a stop loss below $10.00
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Shares of Ramsay Health Care have jumped over 3.5% to $67.25 in early trade after the release of its AGM statement.
According to the release, management reaffirmed that it expects its core earnings per share to grow between 8% and 10% for FY 2018.
Based on the market reaction, investors may have been expecting the company to downgrade its guidance considering that private hospital cover has dropped to it lowest level in five years.
For a high capitalization stock, RHC trades on high volatility and wide trading ranges.
The “lower high” pattern is still in place with key resistance in the $68.30 area and support near the September lows of $61.20.
Concensus EPS for FY18 $2.84 v $2.35 for FY17
Dulux Group reported NPAT up 10% to $142m. FY18 outlook is for 3 – 5 % growth.
We view DLX as full value with the stock now trading 20%+ higher than the Algo Engine buy signal triggered on the 27th July at $6.60.
Or start a free thirty day trial for our full service, which includes our ASX Research.